Fox News senior medical analyst Dr. Marc Siegel joins 'Fox News Live' to discuss how tennis icon Serena Williams was able to ...

The condition MASH (Metabolic Dysfunction-Associated Steatohepatitis) is common and serious.

“Most users tolerate GLP-1 medications like Ozempic without serious oral health issues, but a subset experience notable side ...

Anecdotal reports describe an unusual GLP-1 side effect some are calling "Ozempic vulva," which involves sagging skin, ...

Inspire Medical Systems tumbled on Inspire V delays, but strong growth, buybacks, and low valuation offer upside for patient ...

New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...

Dr. Sterling Elliott, Clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School ...

Tennis legend Serena Williams has revealed that she’s lost 31 pounds over the last eight months using a GLP-1 medication.

A study has found that adults with obesity taking GLP-1 receptor agonists may face significantly lower risk of developing certain cancers. The cohort study was led by researchers from the Indiana ...

Mounjaro and other GLP-1 drugs may lower cancer risk in obese patients, according to a new study. Read more here.

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...